SecBot SecBot
S-3ASR ·Filed Aug 6, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago SEC0001104659-26-092110
Notable filing: S-3ASR
Actionable Insight • Neutral

This is a routine shelf filing with no immediate trading implications. Monitor for future prospectus supplements that would indicate an actual offering, which could signal a change in capital allocation strategy or a need for funding.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$133.21
T+0 close · Aug 6, 2026 · via day close
Latest settled
+27.84%
T+60 · $170.29
Vs SPY
+29.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 7 $133.21entry
  2. T+1 · 3mo ago −0.11%α −0.08% · $133.06
  3. T+5 · 3mo ago +3.87%α +3.47% · $138.36
  4. T+20 · 2mo ago +13.35%α +13.75% · $151.00
  5. T+60 · 15d ago +27.84%α +29.97% · $170.29
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Gilead Sciences filed an automatic shelf registration statement (S-3ASR) on August 6, 2026, registering an indeterminate amount of debt securities, common stock, preferred stock, depositary shares, warrants, subscription rights, stock purchase contracts, and stock purchase units for potential future sale. The filing is a routine administrative step for a large, well-capitalized company, enabling it to access capital markets quickly when needed. No specific offering is being made at this time, and the registration fees are deferred under a pay-as-you-go basis.

Key Facts

  • Gilead filed an S-3ASR on August 6, 2026, registering an indeterminate amount of various securities for potential future sale.
  • The filing is a universal shelf registration, allowing Gilead to offer and sell securities from time to time on a delayed or continuous basis.
  • Registration fees are deferred under Rules 456(b) and 457(r), meaning no immediate offering is being made.
  • The company has a market cap of $163.6B and has filed 5 offering/registration documents in the last 24 months, indicating routine capital management.
  • Net proceeds from any future sale would be used for general corporate purposes.

Financial Impact

No offering size or pricing is disclosed; this is a shelf registration with an indeterminate amount. The filing itself has no immediate financial impact.

Risk Factors

  • Future offerings under this shelf could dilute existing shareholders if common stock is issued.
  • The filing itself does not indicate any immediate capital need or distress.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3ASR Filing (Primary)0001104659-26-092110
Document: tm2621295d2_ex25-1.htm0001104659-26-092110
Document: tm2621295d1_ex-filingfees.htm0001104659-26-092110
Document: tm2621295d2_ex5-1.htm0001104659-26-092110
Document: tm2621295d2_ex23-1.htm0001104659-26-092110
Document: 0001104659-26-092110-index-headers.html0001104659-26-092110
Document: 0001104659-26-092110-index.html0001104659-26-092110
Document: 0001104659-26-092110.txt0001104659-26-092110

Track record

30 reports on GILD

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
  2. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
  3. Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
  6. Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
  7. Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
  8. Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
  9. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
  10. Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026